Clinical Trial Update: Biologically Focused Therapy of Treatment-Refractory MDS Patients

View source ↗

Summary

The clinical trial evaluating a biologically focused therapy for treatment-refractory myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Stanford University | Conditions: Myelodysplastic Syndromes | Status: COMPLETED